An Open-Label Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia
Phase of Trial: Phase III
Latest Information Update: 10 Jan 2019
At a glance
- Drugs Alirocumab (Primary) ; Atorvastatin; Colestyramine; Ezetimibe; Fenofibrate; Fluvastatin; Lovastatin; Nicotinic acids; Omega-3-fatty-acid; Pravastatin; Rosuvastatin; Simvastatin
- Indications Hyperlipoproteinaemia type IIa
- Focus Therapeutic Use
- Sponsors Sanofi
- 29 Aug 2018 Status changed from not yet recruiting to recruiting.
- 24 Jul 2018 Planned initiation date changed from 14 May 2018 to 3 Aug 2018.
- 02 May 2018 New trial record